Every analyst, fund manager and economist who has been on ausbiz. Open an expert to see all of their videos, or follow them to get new ones in My ausbiz.
Generate is proudly New Zealand owned and operated. Our goal is to educate and empower Kiwis to make smart financial decisions that will help them be better off in the future. We have advisers located right across the country, who are able to help Kiwis understand all their KiwiSaver options, so they can set up their accounts in a way that works best for them.
Over 20 years of expertise in financial markets, with a focus on client coverage, equity strategy and strategic leadership. As Head Client Coverage, Pacific, contributions include driving client engagement with asset owners and delivering tailored solutions across diverse investment needs. Previous roles include championing the SPDR ETF Equity range at State Street Global Advisors, where efforts supported large sales opportunities and high profile presentations across APAC. Known for panel discussions and keynote addresses at industry events and an expert on financial media including CNBC, Bloomberg, BBC, Sky News, ABC and SBS.
By background I am an investment professional who did Australian equity research from the late 1990s until early 2015 and again from mid-2016. For a lot of the time I have worked as an analyst I focused on healthcare and biotechnology, and the Life Sciences has become a passion of mine. My forte is making complex, technology-based investment ideas easy to understand. In January 2015 I joined my first biotechnology company, a cancer immunotherapy play called Prima Biomed (Nasdaq: PBMD) and had a great time with them until November 2015. From January until May 2016 I took care of investor relations for another cancer immunotherapy company, Imugene (ASX: IMU). In June 2016 I returned to the equities analyst game with the founding of NDF Research. Two years later in June 2018 I teamed up with Marc Kennis to found Pitt Street Research with the aim of providing issuer-sponsored equity research to the entire spectrum of ASX-listed companies. Please note that any advice given by NDF Research or Pitt Street Research is GENERAL advice.
Chris is an investment and finance professional with over 15 years’ experience working in professional services, corporate and investment management roles in Australia and the United Kingdom. He has a strong interest in equity investing and opportunity analysis, an extensive understanding and awareness of financial markets and advanced financial modelling skills.
Gary Glover has over 18 years experience in financial markets,he assists Private and Institutional clients achieve their investment goals through share and derivatives advisory services . Garys experiences includes roles within some of the largest stockbroking firms in the country as well as roels within Global Investment Banks.
Chris is a global leader in monetization strategy, growth consulting, and go-to-market execution. An expert in portfolio design, pricing, and the application and monetization of AI, he has spent 25 years enabling clients across sectors, sizes, and more than 20 countries to achieve exponential growth. In 2010, he moved to Australia establishing the office of a global consultancy and growing it into a successful practice. Today, Chris is a Venture Partner with an Australian VC firm and an angel investor. Educated in Germany, Sweden, and the US, and a Harvard Business School alumnus, Chris is regularly featured in The Australian Financial Review and other leading business publications, as well as a sought-after keynote speaker at major conferences in Australia and internationally.
Specialties: multi-sector portfolio construction using managed funds and direct assets; TPA/Total Portfolio Approach; dynamic asset allocation; asset class research and modeling; strategy implementation; investment consulting; client service; fund manager research; investment risk and portfolio analysis; experience with Superannuation, institutional client portfolios & outsourced CIO.
Marc JocumInvestment Strategy and Research ManagerGlobal X ETFs
Marc joined Global X in 2023 and is a key contributor to the Product, Strategy and Research teams, with responsibilities including investment research and ETF analysis to facilitate market insights, product development, investment strategy and portfolio construction. Marc has a decade of experience in the industry, previously working at Stockspot, Morgan Stanley, AMP and KPMG. Marc holds a Bachelor of Business from the University of Technology, Sydney (UTS), a Diploma of Financial Planning, and has completed CFA Level 1.
John is a senior sell side analyst at Bell Potter Securities in Sydney . He specialise in small and mid cap healthcare stocks, however, has also followed a wide variety of stocks over 10 years in the securities industry. These range from small biotechs to very large multinationals.. His deep know knowledge of complex stocks including Mayne Pharma, Medibank Private, Sirtex Medical and Viralytics have earned wide recognition from clients during course of 2015 and 2016. In addition to the fundamentals around capital structure and balance sheet strength, he looks for one or more of the following characteristics in a stock: Normally the CEO has had an integral part in establishing the company or providing outstanding vision. Scott Richards at Mayne Pharma and George Saviddes (former CEO of MPL) are good examples. "I take a great deal of confidence from a CEO who has grown with the company and is clever enough to surround himself with an experienced team". Secondly, if it is a technology or biotech stock, the science has to stack up. "I generally steer clear of stocks where there is an absence of solid evidence from clinical trial data. This rules out a lot of start ups and early stage c
Jon Mills, CFA, is an equity analyst for Morningstar.* He covers mining companies, including BHP, Rio Tinto, Vale, Glencore, Anglo American, Barrick, and Newmont. Before joining Morningstar in 2021, Mills worked for two years at a Sydney-based financial technology company. Before that, he was an analyst for nearly four years at an investment research and fund management company.
Will has over five years of experience in the industry, with a strong focus on investment research, relationship management, and portfolio management. Originally from the UK, Will worked at the Royal Bank of Canada as a portfolio manager, overseeing $2 billion for a collection of HNW individuals, companies, and intermediaries. He is a qualified financial advisor (DipPFS), and has attained CFA Levels I and II, ranking in the top decile for both exams. He also holds the CFA Certificate in ESG Investing. Academically, Will achieved a Master of Arts in Economics from the University of Aberdeen and a Master of Science in Economics from the University of St Andrews. His strong academic foundation, combined with his professional qualifications, enable him to approach investments comprehensively, integrating both bottom-up company fundamental analysis and top-down macroeconomic factors.
Portfolio Manager responsible for the Infinity Core Australian Equity Portfolio and conducting fundamental analysis on a range of companies across the ASX.
John ReadeChief Market StrategistWorld Gold Council
As a Gold Strategist with approaching 40 years of experience across many aspects of the gold industry, my role is now to help the World Gold Council to meet the increasing demand for insights and information on the role that gold can play in managing risk and boosting returns in both individual and institutional investor portfolios.
Experts’ views are their own and general in nature. They are not recommendations by ausbiz or ausbiz Invest, and experts may hold the investments they discuss. Consider your own circumstances and get professional advice.
We value your privacy
We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy